Peptides that bind to the erythropoietin receptor
US7414105B2 · kind B2 · utility
2Cited by
45References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 27, 2005 |
| Grant date | Aug 19, 2008 |
| Priority date | — |
| Expiry date | Oct 27, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.